No Data
Kidswell Bio: Summary of financial results for the 2nd quarter (interim period) for the fiscal year ending March 31, 2025 [Japanese GAAP] (consolidated)
Kidswell Bio: Supplementary explanation of financial results for the 2nd quarter of the fiscal year ending March 31, 2025
Kidswell Bio: Notice regarding consolidated earnings forecasts
Kidswell Bio 1H Loss Y241.00M
Daiwa House, Idemitsu Kosan, Tokyo Electron Ltd. unsponsored adr, SoftBank Group (12th)
※Please note that the above calendar is subject to change depending on the company's circumstances. --------------------------------------- November 12 (Tuesday) ＜1431＞ Livework ＜146A＞ Colombia ＜148A＞ Hatchwork ＜1491＞ Chugai Mining ＜1605＞ INPEX ＜1663＞ K&O Energy ＜166A＞ Taski HD ＜1770＞ Fujita E
hot stocks digest (morning session): Adastria, Rohm, Shimamura, etc.
KOA <6999>: ¥1102 (-¥31) Significant further decline. It announced a downward revision of the financial estimates for the fiscal year ending March 2025 on the previous day. Operating profit has been revised down from the previous estimate of 3.9 billion yen to 1.6 billion yen, a decrease of 51.7% compared to the previous year. Stagnation in automobile sales volume, as well as continued sluggish demand in the industrial machinery and consumer electronics markets due to Asia's economic stunk, leading to customer inventory adjustments lasting longer than expected. As a result, the recovery in demand for resistors is expected to be delayed until the next fiscal year and beyond, based on current projections of underperformance from the first quarter results.
No Data
No Data